Plain-English translation of NCT06867926 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether cardiac rehabilitation—a supervised exercise and wellness program—can help reduce harmful inflammation and genetic damage in people with coronary artery disease. Researchers know that heart disease involves damaging processes in your body's cells, and they want to see if regular, moderate exercise can help reverse some of that damage. You would participate in the rehabilitation program while researchers monitor changes in your blood and overall health.
While exercise is known to be good for heart disease patients, doctors still don't fully understand how it works at the cellular level or whether it truly reduces the dangerous inflammation and genetic damage that occurs with this condition. This study aims to fill that gap by measuring specific markers of cellular damage before and after the treatment.
You likely qualify if…
You likely don't qualify if…
If you're in the patient group, you'll undergo an initial exercise test to measure your fitness baseline. Then you'll participate in a structured cardiac rehabilitation program that combines supervised exercise sessions with medical guidance. Your blood will be drawn before and after the program to measure inflammation and genetic damage markers. Healthy volunteers will provide blood samples for comparison but won't participate in the exercise program.
AI-generated summary from trial data · Jun 17, 2026 · Not medical advice
Turkey (Türkiye)